The trajectory of Viagra presents a interesting case for stakeholders in the pharmaceutical sector. While initially a phenomenal success, generating huge profits, the intellectual property lapse and the subsequent entry of off-brand versions have drastically changed income. This presents questions about the long-term sustainability of analogous … Read More